IRIS
GRELLI, SANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.539
EU - Europa 2.524
AS - Asia 1.516
SA - Sud America 14
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 8
AF - Africa 5
Totale 29.619
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.521
SG - Singapore 680
CN - Cina 626
IT - Italia 542
UA - Ucraina 367
DE - Germania 352
IE - Irlanda 301
RU - Federazione Russa 228
SE - Svezia 207
FR - Francia 145
GB - Regno Unito 134
KR - Corea 91
FI - Finlandia 87
PL - Polonia 63
VN - Vietnam 36
JP - Giappone 27
BE - Belgio 21
CZ - Repubblica Ceca 18
IN - India 18
CA - Canada 17
NL - Olanda 17
PK - Pakistan 17
ES - Italia 12
EU - Europa 11
CH - Svizzera 8
AU - Australia 7
BR - Brasile 7
CL - Cile 6
GR - Grecia 6
AT - Austria 5
AL - Albania 4
TH - Thailandia 4
HK - Hong Kong 3
PH - Filippine 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
IL - Israele 2
UZ - Uzbekistan 2
AO - Angola 1
AR - Argentina 1
BD - Bangladesh 1
DZ - Algeria 1
HR - Croazia 1
ID - Indonesia 1
IR - Iran 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LY - Libia 1
MU - Mauritius 1
MX - Messico 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
TW - Taiwan 1
Totale 29.619
Salva come PNG Salva come JPEG
Città #
Woodbridge 7.228
Wilmington 7.006
Houston 5.986
Fairfield 788
Chandler 681
Singapore 578
Ann Arbor 527
Ashburn 358
Jacksonville 306
Seattle 304
Dublin 279
Cambridge 267
Zhengzhou 259
Rome 240
Medford 203
Dearborn 171
Santa Clara 139
Beijing 134
New York 114
Lawrence 96
Boardman 63
Mülheim 58
Kraków 54
Milan 49
Shanghai 42
Moscow 41
Hangzhou 39
Menlo Park 39
San Diego 38
Creede 34
Dong Ket 33
Palo Alto 30
Hefei 22
Munich 22
Brussels 21
Norwalk 21
Seoul 21
University Park 21
Helsinki 19
Brno 17
London 16
Redwood City 16
San Mateo 16
Toronto 15
Falls Church 14
Kunming 14
Lahore 14
Nanjing 14
Verona 13
Guangzhou 12
Mountain View 12
Cedarhurst 11
Saint Petersburg 11
Los Angeles 10
Phoenix 10
Chengdu 9
Council Bluffs 9
Engelhard 9
Jinan 9
Kilburn 9
Takasaki 9
Auburn Hills 8
Bologna 8
Fuzhou 7
Nürnberg 7
Amsterdam 6
Detroit 6
Genzano di Roma 6
Hounslow 6
Madrid 6
Nanchang 6
San Francisco 6
San Jose 6
St. George 6
The Dalles 6
Hackensack 5
Latina 5
Paris 5
Redmond 5
Ridgeland 5
Bangkok 4
Durham 4
Florence 4
Groningen 4
Haikou 4
Indiana 4
Lappeenranta 4
Manitou Springs 4
Nuremberg 4
Shenyang 4
Southwark 4
Tappahannock 4
Warsaw 4
Yongsan-gu 4
Acton 3
Athens 3
Baotou 3
Chicago 3
Forlì 3
Giffoni Valle Piana 3
Totale 26.789
Salva come PNG Salva come JPEG
Nome #
Combination treatment with zidovudine, thymosin alpha 1 and interferon-alpha in human immunodeficiency virus infection. 496
Changes in apoptosis after interruption of potent antiretroviral therapy in patients with maximal HIV-1-RNA suppression 468
Thymosin α 1 potentiates the release by CD8(+) cells of soluble factors able to inhibit HIV-1 and human T lymphotropic virus 1 infection in vitro 449
Susceptibility to influenza A virus infection in mice immunosuppressed with cyclophosphamide 443
Identification of nuclei from apoptotic, necrotic, and viable lymphoid cells by using multiparameter flow cytometry 441
Approaches towards the synthesis of 7-halo-1,2-dihydroxyindolizidines (7-halolentiginosines) thwarting Grob fragmentation processes 441
Antitumour effect of OM-174 and cyclophosphamide on murine B16 melanoma in different experimental conditions 438
D(-)lentiginosine-induced apoptosis involves the intrinsic pathway and is p53-independent 437
AZT inhibits the transmission of human T cell leukaemia/lymphoma virus type I to adult peripheral blood mononuclear cells in vitro 434
Thymosin alpha 1 and HIV-1: Recent advances and future perspectives 431
Spontaneous and anti-Fas-induced apoptosis in lymphocytes from HIV-infected patients undergoing highly active anti-retroviral therapy 430
Role of Bcl-2 expression for productive herpes simplex virus 2 replication 430
Testing anti-HIV activity of antiretroviral agents in vitro using flow cytometry analysis of CEM-GFP cells infected with transfection-derived HIV-1 NL4-3 430
Interleukin 4 stimulates infection and temporary growth of human neonatal lymphocytes exposed in vitro to human T-lymphotropic virus type I, but fails to substitute for interleukin 2 in the immortalization of infected cultures 428
Correlation between induction of lymphocyte apoptosis and prostaglandin E2 production by macrophages infected with HIV 428
Umbilical cord blood: the role of apoptosis in the control of CD34+ cell counts 427
Leucocyte rheological properties are altered in patients with diffuse atherosclerosis 424
Thymic hormones and cytokines 422
Involvement of gD/HVEM interaction in NF-kappa B-dependent inhibition of apoptosis by HSV-1 gD 416
Interleukin 4 stimulates infection and temporary growth of human neonatal lymphocytes exposed in vitro to human T-lymphotropic virus type I, but fails to substitute for interleukin 2 in the immortalization of infected cultures 413
Inverse correlation between CD8+ lymphocyte apoptosis and CD4+ cell counts during potent antiretroviral therapy in HIV patients 408
Immunological and endocrinological disturbances in patients after prolonged coma following head injury 398
Involvement of HVEM receptor in activation of nuclear factor kappa B by herpes simplex virus 1 glycoprotein D 397
Herpes simplex virus 2 causes apoptotic infection in monocytoid cells 394
Efficacy of 3 '-azido 3 ' deoxythymidine (AZT) in preventing HTLV-1 transmission to human cord blood mononuclear cells 392
CD4+ lymphocyte increases in HIV patients during potent antiretroviral therapy are dependent on inhibition of CD8+ cell apoptosis 392
Signaling pathway used by HSV-1 to induce NF-kappa B activation - Possible role of herpes virus entry receptor A 390
In vivo and in vitro studies support that a new splicing isoform of OLR1 gene is protective against acute myocardial infarction 390
Effect of di-M-PGE2 on T cell differentiation. Flow cytometry study at thymus level 389
Synergistic effect of thymosin alpha 1 and alpha beta-interferon on NK activity in tumor-bearing mice 388
Combined treatment with thymosin alpha 1 and interferon enhances NK activity in immunosuppressed tumor bearing mice 388
Induction of apoptosis in thymocytes by prostaglandin E2 in vivo 384
Correlation between the effects of prostaglandins and interferon on B-16 melanoma growth and their modulation on natural killer activity 383
Apoptotic cell signaling in lymphocytes from HIV+ patients during successful therapy 382
(-)-(1R,2R,7S,8aR)-1,2,7-trihydroxyindolizidine ((-)-7S-OH-lentiginosine): Synthesis and proapoptotic activity 382
Studies on the induction of human lymphocyte apoptosis by prostaglandin-E2 380
Infection with Helicobacter pylori and leukocyte response in patients with myocardial infarction 376
Flow cytometric method for the evaluation of the biological activity of thymic hormones 373
Modifications in spleen lymphocyte subsets after cyclophosphamide and 16,16-dimethyl prostaglandin E2 administration in mice 371
Thymosin-alpha 1 regulates MHC class I expression in FRTL-5 cells at transcriptional level 369
HSV-1-induced activation of NF-κB protects U937 monocytic cells against both virus replication and apoptosis 368
Thymosin alpha 1 potentiates interleukin 2-induced cytotoxic activity in mice 366
Lymphocytes as liver damage mirror of HCV related adipogenesis deregulation 366
Satraplatin (JM-216) mediates G2/M cell cycle arrest and potentiates apoptosis via multiple death pathways in colorectal cancer cells thus overcoming platinum chemo-resistance 364
The novel proapoptotic activity of nonnatural enantiomer of Lentiginosine 363
Platinum-(IV)-derivative satraplatin induced G2/M cell cycle perturbation via p53-p21(waf1/cip1)-independent pathway in human colorectal cancer cells 363
Immunological events during the early phase of infection with Schistosoma mansoni in mice 362
Recombinant interferon alpha 2a, thymopentin and low doses of cytosine arabinoside for the treatment of myelodysplastic syndromes: a pilot study 360
Increased caspase activation in peripheral blood mononuclear cells of patients with Alzheimer’s disease 358
Apoptosis-associated gene expression in HIV-infected patients in response to successful antiretroviral therapy 357
Interaction between thymic hormones and other immunomodulatory agents 355
Restoration of peripheral blood natural killer and B cell levels in patients affected by rheumatoid and psoriatic arthritis during etanercept treatment 355
Effector caspase activation, in the absence of a conspicuous apoptosis induction, in mononuclear cells treated with azidothymidine 351
Role of inflammation and apoptosis in multiple sclerosis: Comparative analysis between the periphery and the central nervous system 345
Effects of in vivo administration of di-M-PGE2 on spleen and thymus lymphocyte subsets in mice. 342
Characterization of the enhanced apoptotic response to azidothymidine by pharmacological inhibition of NF-kB. 339
Synergistic effect of thymosin α1 and αβ-interferon on NK activity in tumor-bearing mice 338
Valutazione dell'attività citotossica in modelli animali di immuno-soppressione dopo trattamento combinato con ormoni timici/interferone ed in soggetti HIV positivi . 334
Significato e limiti dello screening sierologico nella profilassi antitetanica in ambito occupazionale. 317
Effetti di terapie combinate con timosina alfa 1, interleuchina 2 ed interferone in topi inoculati con cellule di leucemia di Friend. 311
Possible role of prostaglandin E2 in induction of lymphocyte apoptosis during HIV infection. Vol. 9 308
Quantification of HTLV-1 reverse transcriptase activity in ATL patients treated with zidovudine and interferon-alpha 308
Deciphering cellular biological processes to clinical application: a new perspective for Tα1 treatment targeting multiple diseases 304
High expression of Endogenous Retroviruses from intrauterine life to adulthood in two mouse models of Autism Spectrum Disorders 300
Rationale for therapeutic approaches with thymic hormones, interleukin 2 and interferon in combination with chemotherapy. 293
Interaction between thymic hormones and other immunomodulating agents on the cell-mediated immune response. 280
NF-κB-Dependent Production of ROS and Restriction of HSV-1 Infection in U937 Monocytic Cells 266
Cell death pathologies: targeting death pathways and the immune system for cancer therapy 265
Focus on recently developed assays for detection of resistance/sensitivity to reverse transcriptase inhibitors 255
Measles immunity in an Italian teaching hospital 242
Future perspectives on drug targeting in adult T cell leukemia-lymphoma 239
Children with autism spectrum disorder and their mothers share abnormal expression of selected endogenous retroviruses families and cytokines 190
Naïve/Effector CD4 T cell ratio as a useful predictive marker of immune reconstitution in late presenter HIV patients: A multicenter study 181
Tuberculosis-related hospitalizations in a low-incidence country: A retrospective analysis in two Italian infectious diseases wards 175
Skin immunity and its dysregulation in atopic dermatitis, hidradenitis suppurativa and vitiligo 171
Cytotoxic and apoptotic effects of different extracts of Moringa oleifera Lam on lymphoid and monocytoid cells 164
Expression profiles of the SARS-CoV-2 host invasion genes in nasopharyngeal and oropharyngeal swabs of COVID-19 patients 164
Inhibition of IκBα phosphorylation potentiates regulated cell death induced by azidothymidine in HTLV-1 infected cells 160
The Concomitant Expression of Human Endogenous Retroviruses and Embryonic Genes in Cancer Cells under Microenvironmental Changes is a Potential Target for Antiretroviral Drugs 149
Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patients 123
Endogenous retroviruses activity as a molecular signature of neurodevelopmental disorders 113
Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection 111
Antiretroviral therapy in HTLV-1 infection: an updated overview 107
Appraisal of a Simple and Effective RT-qPCR Assay for Evaluating the Reverse Transcriptase Activity in Blood Samples from HIV-1 Patients 97
Effect of microvesicles from Moringa oleifera containing miRNA on proliferation and apoptosis in tumor cell lines 95
Breast cancer patients with hormone neoadjuvant bridging therapy due to asymptomatic Corona virus infection. Case report, clinical and histopathologic findings 91
High body mass index and night shift work are associated with COVID-19 in health care workers 87
SARS-CoV-2 infection serology: a useful tool to overcome lockdown? 80
HBeAg Levels Vary across the Different Stages of HBV Infection According to the Extent of Immunological Pressure and Are Associated with Therapeutic Outcome in the Setting of Immunosuppression-Driven HBV Reactivation 64
Inhibition of HECT E3 ligases as potential therapy for COVID-19 63
Interaction of Pelargonium sidoides Compounds with Lactoferrin and SARS-CoV-2: Insights from Molecular Simulations 61
T-cell responses to SARS-CoV-2 in Multiple Sclerosis patients treated with ocrelizumab healed from COVID-19 with absent or low anti-Spike antibody titers 59
B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications 55
Thymosin Alpha 1 Mitigates Cytokine Storm in Blood Cells From Coronavirus Disease 2019 Patients 52
High CD169 monocyte/lymphocyte ratio reflects immunophenotype disruption and oxygen need in COVID-19 patients 50
Modulation of human endogenous retroviruses and cytokines expression in peripheral blood mononuclear cells from autistic children and their parents 42
Post-Mortem RT-PCR Assay for SARS-CoV-2 RNA in COVID-19 Patients' Corneal Epithelium, Conjunctival and Nasopharyngeal Swabs 41
Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients 40
Infection Rate of Respiratory Viruses in the Pandemic SARS-CoV-2 Period Considering Symptomatic Patients: Two Years of Ongoing Observations 40
First Case of a COVID-19 Patient Infected by Delta AY.4 with a Rare Deletion Leading to a N Gene Target Failure by a Specific Real Time PCR Assay: Novel Omicron VOC Might Be Doing Similar Scenario? 37
Totale 29.388
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.329
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.329
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.063 0 0 0 0 590 785 721 623 717 612 468 547
2020/20214.847 509 590 468 588 554 498 621 535 121 99 161 103
2021/20221.219 67 138 65 67 29 144 74 62 109 111 49 304
2022/20231.815 158 171 60 254 157 344 154 165 132 12 139 69
2023/2024726 96 20 47 26 69 153 43 32 18 52 44 126
2024/20251.389 119 650 343 197 80 0 0 0 0 0 0 0
Totale 30.078